(Q35559022)

8 August 2017

title

Evaluation of the impact of Dublin's expanded harm reduction programme on prevalence of hepatitis C among short-term injecting drug users (English)

1 reference

8 August 2017

1 reference

1 reference

1

Smyth BP

1 reference

8 August 2017

Keenan E

2

1 reference

8 August 2017

O'Connor JJ

series ordinal

3

1 reference

8 August 2017

publication date

1 July 1999

1 reference

Journal of Epidemiology and Community Health

8 August 2017

published in

1 reference

8 August 2017

volume

53

1 reference

8 August 2017

issue

7

1 reference

8 August 2017

page(s)

434-435

1 reference

Once more unto the breach: controlling hepatitis C in injecting drug users

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756924

Deaths, HIV infection, abstinence, and other outcomes in a cohort of injecting drug users followed up for 10 years

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756924

Changes in the injecting risk behaviour of injecting drug users in London, 1990-1993

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756924

Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756924

Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program

26 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10492738

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/JECH.53.7.434

1 reference

8 August 2017

1 reference

8 August 2017

1 reference